Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Low testosterone is associated with disability in men with multiple sclerosis.
Episode 40 with Dr. Raj Kapoor on a clinical trial of phenytoin
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
ISN-APSN Biennial Meeting
USPTO list of patent term extensions
The origin and application of experimental autoimmune encephalomyelitis.
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Episode 65 with Dr. Gisela Kobelt on the economics of long-term brain health in MS
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
Glatiramer promotes oligodendroglial cell maturation in a cuprizone-induced demyelination model.
The Oxford English Corpus: Facts about the language, The Story of Dictionaries
Primary progressive multiple sclerosis-why we are failing.
The Role of the Gut Microbiome on Multiple Sclerosis Risk and Progression
Sustained cortical and subcortical neuromodulation induced by electrical tongue stimulation.
Episode 43 with Dr. May Han on following patients through the course of their disease
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.
Petite but Potent
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
ACTRIMS-ECTRIMS 2014 -- Day 3, afternoon
Risk alleles for multiple sclerosis identified by a genomewide study.
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
…
next ›
last »